PMC:7696151 / 19989-20156
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 563 | 73-84 | Chemical | denotes | aceclofenac | MESH:C056498 |
| 564 | 86-89 | Chemical | denotes | ACF | MESH:C056498 |
| 565 | 103-106 | Chemical | denotes | HCQ | MESH:D006886 |
| 566 | 122-134 | Chemical | denotes | prednisolone | MESH:D011239 |
| 567 | 136-139 | Chemical | denotes | PRD | MESH:D011239 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T142 | 0-167 | Sentence | denotes | A total of 120 subjects were divided into groups treated with 200 mg/day aceclofenac (ACF), 400 mg/day HCQ, and 10 mg/day prednisolone (PRD) in different combinations. |